Skip to main content
EVENT REGISTRATION LOGIN
|
STAFF LOGIN
|
Mountain Navigation
About Us
Partners
Alaska
Colorado
Idaho
Montana
North & South Dakota
Oregon
Utah
Washington
Wyoming
Programs
AIDS Clinical Conference
Corrections
MWAETC HIV ECHO
Preceptorships
Practice Transformation
Interprofessional Education Project (IPE) Program
Diversity, Equity, and Inclusivity Initiatives
Dental Program
MWAETC On-Demand
Resources
Clinical Consultations & Guidelines
Service Locators & Referrals
General HIV Info Lines/Tool Kits/Resources
Population Specific
Co-Morbidities
Online Self-Service Learning - HIV/HBV/HCV/STD
Calendar
Jobs
Contact Us
For Participants
Search
Contact navigation
Regional Office
Alaska
Colorado
Idaho
Montana
North and South Dakota
Oregon
Utah
Washington
Wyoming
Regional Contacts
OD presentation return node
« Return to MWAETC On-Demand Presentations
menu title
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV
« Return to MWAETC On-Demand Presentations
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV
Presentation Date:
2022-04-28
Presentation Length:
18:35
Presenters:
Chris Longenecker, MD
Presentation Categories:
HIV ECHO
Presentation Tags:
Common Co-Occurring Conditions
,
Aging and HIV
,
Anti-Retroviral Therapy (ART)
Presentation Slides:
Download (1.534 MB)
Presentation Downloads:
Related Documents:
Related Links:
Related Presentations:
Presentation Details:
Dr. Chris Longenecker from University of Washington Cardiology discusses ASCVD risk prediction to guide initial statin therapy for people with HIV.
Presentation Transcript: